Results of resection of forearm soft tissue sarcoma.
Forearm
Function
Prognosis
Soft tissue sarcomas
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
14 Aug 2023
14 Aug 2023
Historique:
received:
08
06
2023
accepted:
09
08
2023
medline:
16
8
2023
pubmed:
15
8
2023
entrez:
14
8
2023
Statut:
epublish
Résumé
Soft tissue sarcomas (STS) of the forearm are rare. We aim to assess their oncological and functional outcomes. We retrospectively evaluated 34 patients who underwent surgical excision for forearm STS at our institution between 1993 and 2020. We analyzed postoperative Musculoskeletal Tumor Society rating scale (MSTS) and local recurrence-free survival (LRFS), metastasis-free survival, and overall survival (OS) rates. The significance of the following variables was determined: age, sex, histology, tumor size, Fédération Nationale des Centres de Lutte contre le Cancer grade, American Joint Committee on Cancer stage, surgical margin, unplanned excision, metastases upon initial presentation, receipt of chemotherapy, and radiotherapy (RT). The postoperative median MSTS score was 28. Bone resection or major nerve palsy was the only factor that influenced MSTS scores. The median MSTS scores in patients with or without bone resection or major nerve palsy were 24 and 29, respectively (P < 0.001). The 5-year LRFS rates was 87%. Univariate analysis revealed that the histological diagnosis of myxofibrosarcoma was the only factor that influenced LRFS (P = 0.047). The 5-year MFS rates was 71%. In univariate analysis, no factors were associated with MFS. The 5-year OS rates was 79%. Age was the only factor that influenced OS (P = 0.01). In the treatment of forearm STS, reconstruction of the skin and tendon can compensate for function, while bone resection and major nerve disturbance cannot. Careful follow-up is important, especially in patients with myxofibrosarcoma, due to its likelihood of local recurrence.
Identifiants
pubmed: 37580775
doi: 10.1186/s13018-023-04088-7
pii: 10.1186/s13018-023-04088-7
pmc: PMC10424346
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
599Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Collin C, Hajdu SI, Godbold J, Friedrich C, Brennan MF. Localized operable soft tissue sarcoma of the upper extremity. Presentation, management, and factors affecting local recurrence in 108 patients. Ann Surg. 1987;205:331–9. https://doi.org/10.1097/00000658-198704000-00001 .
doi: 10.1097/00000658-198704000-00001
pubmed: 3566371
pmcid: 1492734
Duran-Moreno J, Kontogeorgakos V, Koumarianou A. Soft tissue sarcomas of the upper extremities: Maximizing treatment opportunities and outcomes. Oncol Lett. 2019;18:2179–91. https://doi.org/10.3892/ol.2019.10575 .
doi: 10.3892/ol.2019.10575
pubmed: 31404317
pmcid: 6676724
Gustafson P, Arner M. Soft tissue sarcoma of the upper extremity: descriptive data and outcome in a population-based series of 108 adult patients. J Hand Surg Am. 1999;24:668–74. https://doi.org/10.1053/jhsu.1999.0668 .
doi: 10.1053/jhsu.1999.0668
pubmed: 10447155
Koulaxouzidis G, Simunovic F, Bannasch H. Soft tissue sarcomas of the arm—oncosurgical and reconstructive principles within a multimodal, interdisciplinary setting. Front Surg. 2016;23:12. https://doi.org/10.3389/fsurg.2016.00012 .
doi: 10.3389/fsurg.2016.00012
Lazerges C. Soft tissue sarcomas of the forearm, wrist and hand. Hand Surg Rehabil. 2017;36:233–43. https://doi.org/10.1016/j.hansur.2016.12.010 .
doi: 10.1016/j.hansur.2016.12.010
pubmed: 28624293
Muramatsu K, Ihara K, Yoshida K, Tominaga Y, Hashimoto T, et al. Musculoskeletal sarcomas in the forearm and hand: standard treatment and microsurgical reconstruction for limb salvage. Anticancer Res. 2013;33:4175–82.
pubmed: 24122980
Bray PW, Bell RS, Bowen CV, Davis A, O’Sullivan B. Limb salvage surgery and adjuvant radiotherapy for soft tissue sarcomas of the forearm and hand. J Hand Surg Am. 1997;22:495–503. https://doi.org/10.1016/S0363-5023(97)80019-6 .
doi: 10.1016/S0363-5023(97)80019-6
pubmed: 9195461
Mundinger GS, Prucz RB, Frassica FJ, Deune EG. Concomitant upper extremity soft tissue sarcoma limb-sparing resection and functional reconstruction: assessment of outcomes and costs of surgery. Hand. 2014;9:196–204. https://doi.org/10.1007/s11552-013-9567-9 .
doi: 10.1007/s11552-013-9567-9
pubmed: 24839421
Muramatsu K, Ihara K, Doi K, Hashimoto T, Taguchi T. Sarcoma in the forearm and hand: clinical outcomes and microsurgical reconstruction for limb salvage. Ann Plast Surg. 2009;62:28–33. https://doi.org/10.1097/SAP.0b013e3181743a11 .
doi: 10.1097/SAP.0b013e3181743a11
pubmed: 19131715
Vetter M, Germann G, Bickert B, Sauerbier M. Current strategies for sarcoma reconstruction at the forearm and hand. J Reconstr Microsurg. 2010;26:455–60. https://doi.org/10.1055/s-0030-1254229 .
doi: 10.1055/s-0030-1254229
pubmed: 20458673
Baroudi MR, Ferguson PC, Wunder JS, Isler MH, Mottard S, et al. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery. J Surg Oncol. 2014;110:676–81. https://doi.org/10.1002/jso.23686 .
doi: 10.1002/jso.23686
pubmed: 24910319
Heer J, Allison DC, Helmstedter CS. Factors, treatments, and outcomes associated with primary soft tissue malignancies of the forearm: a series of 31 cases. J Orthop. 2021;11(28):58–61. https://doi.org/10.1016/j.jor.2021.11.001 .
doi: 10.1016/j.jor.2021.11.001
Morattel B, Mustaki L, Montemurro M, Letovanec I, Durham AD, et al. Oncological outcome, functional results and costs after unplanned excision of musculoskeletal soft tissue sarcoma. Eur J Surg Oncol. 2020;46:898–904. https://doi.org/10.1016/j.ejso.2020.01.025 .
doi: 10.1016/j.ejso.2020.01.025
pubmed: 32037016
Potter BK, Adams SC, Pitcher JD Jr, Temple HT. Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res. 2008;466:3093–100. https://doi.org/10.1007/s11999-008-0529-4 .
doi: 10.1007/s11999-008-0529-4
pubmed: 18818981
pmcid: 2628223
Pretell-Mazzini J, Barton MD Jr, Conway SA, Temple HT. Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis. J Bone Joint Surg Am. 2015;97:597–603. https://doi.org/10.2106/JBJS.N.00649 .
doi: 10.2106/JBJS.N.00649
pubmed: 25834085
Qureshi YA, Huddy JR, Miller JD, Strauss DC, Thomas JM, et al. Unplanned excision of soft tissue sarcoma results in increased rates of local recurrence despite full further oncological treatment. Ann Surg Oncol. 2012;19:871–7. https://doi.org/10.1245/s10434-011-1876-z .
doi: 10.1245/s10434-011-1876-z
pubmed: 21792512
Fletcher CDM. WHO classification of tumours of soft tissue and bone. 5th ed. Lion: IARC Press; 2020.
Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15:350–62. https://doi.org/10.1200/JCO.1997.15.1.350 .
doi: 10.1200/JCO.1997.15.1.350
pubmed: 8996162
Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, et al. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer. 2009;115:3483–8. https://doi.org/10.1002/cncr.24320 .
doi: 10.1002/cncr.24320
pubmed: 19536900
Jones NF, Machado GR. Tendon transfers for radial, median, and ulnar nerve injuries: current surgical techniques. Clin Plast Surg. 2011;38:621–42. https://doi.org/10.1016/j.cps.2011.07.002 .
doi: 10.1016/j.cps.2011.07.002
pubmed: 22032590
Seiler JG 3rd, Desai MJ, Payne SH. Tendon transfers for radial, median, and ulnar nerve palsy. J Am Acad Orthop Surg. 2013;21:675–84. https://doi.org/10.5435/JAAOS-21-11-675 .
doi: 10.5435/JAAOS-21-11-675
pubmed: 24187037
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–6.
doi: 10.1097/00003086-199301000-00035
Crimì A, Binitie OT, Crimì F, Letson GD, Joyce DM. Outcomes and complications of pelvic chondrosarcomas treated using navigation guidance and multidisciplinary approach: is the tumor volume a prognostic factor? J Clin Med. 2022;30:7111. https://doi.org/10.3390/jcm11237111 .
doi: 10.3390/jcm11237111
Angelini A, Tiengo C, Sonda R, Berizzi A, Bassetto F, Ruggieri P. Stage soft tissue reconstruction following sarcoma excision: a personalized multidisciplinary approach called “orthoplasty.” J Pers Med. 2020;10(4):278. https://doi.org/10.3390/jpm10040278 .
doi: 10.3390/jpm10040278
pubmed: 33327387
pmcid: 7768416
Lee N, Roh S, Yang K, Kim J. Reconstruction of hand and forearm after sarcoma resection using anterolateral thigh free flap. J Plast Reconstr Aesthet Surg. 2009;62:584–6. https://doi.org/10.1016/j.bjps.2008.11.118 .
doi: 10.1016/j.bjps.2008.11.118
Lucattelli E, Lusetti IL, Cipriani F, Innocenti A, De Santis G, et al. Reconstruction of upper limb soft-tissue defects after sarcoma resection with free flaps: a systematic review. J Plast Reconstr Aesthet Surg. 2020;74:755–67. https://doi.org/10.1016/j.bjps.2020.10.065 .
doi: 10.1016/j.bjps.2020.10.065
pubmed: 33277214
Kang S, Han I, Kim S, Lee YH, Kim MB, et al. Outcomes after flap reconstruction for extremity soft tissue sarcoma: a case-control study using propensity score analysis. Eur J Surg Oncol. 2014;40:1101–8. https://doi.org/10.1016/j.ejso.2014.05.004 .
doi: 10.1016/j.ejso.2014.05.004
pubmed: 24915855
Payne CE, Hofer SO, Zhong T, Griffin AC, Ferguson PC, et al. Functional outcome following upper limb soft tissue sarcoma resection with flap reconstruction. J Plast Reconstr Aesthet Surg. 2013;66:601–7. https://doi.org/10.1016/j.bjps.2013.01.034 .
doi: 10.1016/j.bjps.2013.01.034
pubmed: 23434111
Slump J, Hofer SOP, Ferguson PC, Wunder JS, Griffin AM, et al. Flap choice does not affect complication rates or functional outcomes following extremity soft tissue sarcoma reconstruction. J Plast Reconstr Aesthet Surg. 2018;71:989–96. https://doi.org/10.1016/j.bjps.2018.04.002 .
doi: 10.1016/j.bjps.2018.04.002
pubmed: 29706552
Dadrass F, Gusho C, Yang F, Culvern C, Bloom J, et al. A clinicopathologic examination of myxofibrosarcoma. Do surgical margins significantly affect local recurrence rates in this infiltrative sarcoma subtype? Surg Oncol. 2021;123:489–96. https://doi.org/10.1002/jso.26277 .
doi: 10.1002/jso.26277
Lin CN, Chou SC, Li CF, Tsai KB, Chen WC, et al. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival. J Surg Oncol. 2006;93:294–303. https://doi.org/10.1002/jso.20425 .
doi: 10.1002/jso.20425
pubmed: 16496357
Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. Surg Oncol Clin N Am. 2016;25:775–88. https://doi.org/10.1016/j.soc.2016.05.008 .
doi: 10.1016/j.soc.2016.05.008
pubmed: 27591498